Does ROSUVASTATIN Cause Cardiomyopathy? 118 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Cardiomyopathy have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.3% of all adverse event reports for ROSUVASTATIN.
118
Reports of Cardiomyopathy with ROSUVASTATIN
0.3%
of all ROSUVASTATIN reports
6
Deaths
31
Hospitalizations
How Dangerous Is Cardiomyopathy From ROSUVASTATIN?
Of the 118 reports, 6 (5.1%) resulted in death, 31 (26.3%) required hospitalization, and 7 (5.9%) were considered life-threatening.
Is Cardiomyopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 118 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Cardiomyopathy?
DOXORUBICIN (820)
CYCLOPHOSPHAMIDE (581)
SACUBITRIL\VALSARTAN (444)
CLOZAPINE (404)
PREDNISONE (379)
RITUXIMAB (379)
ROSIGLITAZONE (374)
VINCRISTINE (326)
TRASTUZUMAB (292)
HYDROXYCHLOROQUINE (231)
Which ROSUVASTATIN Alternatives Have Lower Cardiomyopathy Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN